OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma
Yating Liu, Lianlian Ouyang, Chao Mao, et al.
Oncogene (2022) Vol. 41, Iss. 27, pp. 3570-3583
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 192

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 158

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72

Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang, Guido Kroemer, Rui Kang
Hepatology (2023) Vol. 80, Iss. 3, pp. 721-739
Closed Access | Times Cited: 27

Ferroptosis in gastrointestinal cancer: from mechanisms to implications
Ruoxi Zhang, Rui Kang, Daolin Tang
Cancer Letters (2023) Vol. 561, pp. 216147-216147
Open Access | Times Cited: 24

From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma
Zijian Wang, Chunyang Zhou, Yiming Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116074-116074
Open Access | Times Cited: 22

Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine
Daiha Shin, Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 585, pp. 216645-216645
Closed Access | Times Cited: 10

Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
Xinyue Zhu, Xudong Sha, Yan Zang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3621-3637
Open Access | Times Cited: 10

The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis
Zuli Wang, Lianlian Ouyang, Na Liu, et al.
Oncogene (2023) Vol. 42, Iss. 36, pp. 2688-2700
Open Access | Times Cited: 19

Ferroptosis regulation by methylation in cancer
Mengqiu Hao, Yixin Jiang, Yang Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188972-188972
Closed Access | Times Cited: 17

Insights into the Roles of Epigenetic Modifications in Ferroptosis
Jinghua Kong, Hao Lyu, Qian Ouyang, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 122-122
Open Access | Times Cited: 7

Ferroptosis: A Targetable Vulnerability for Melanoma Treatment
Meng Yu, Qian Zhou, Yating Dian, et al.
Journal of Investigative Dermatology (2025)
Open Access

Protocadherin 17 weakens the lenvatinib resistance of liver cancer through inducing ferroptosis
Jun Yang, Bin Hu, Guowei Zhang, et al.
Experimental Cell Research (2025) Vol. 447, Iss. 1, pp. 114495-114495
Open Access

Targeting ferroptosis in hepatocellular carcinoma
Yuqian Mo, Zhilin Zou, Erbao Chen
Hepatology International (2023) Vol. 18, Iss. 1, pp. 32-49
Closed Access | Times Cited: 11

Novel Epitranscriptomic and Epigenetic Therapeutic Strategies and Targets for Ferroptosis in Liver Fibrosis
Minghui Li, Yang Yang, Qi-Qi Dong, et al.
European Journal of Pharmacology (2025) Vol. 996, pp. 177344-177344
Closed Access

ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance
Jianing Tang, Guo Long, Desheng Xiao, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 9

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Ferroptosis: insight into the treatment of hepatocellular carcinoma
Chuanjie Liao, Youwu He, Xingju Luo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers
Hikaru Murakami, Masami Hayashi, Shinichi Terada, et al.
Life Sciences (2023) Vol. 325, pp. 121753-121753
Open Access | Times Cited: 8

Targeting ferroptosis opens new avenues in gliomas
Yuxin Wei, Yang Xu, Qian Sun, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4674-4690
Open Access | Times Cited: 2

Clinical and prognostic significance of FBXL6 expression in ovarian cancer
Dianxin Tao, Shenghan Lou, Wei Huang, et al.
Gene (2024) Vol. 933, pp. 148978-148978
Open Access | Times Cited: 2

Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma
Lei Yang, Yu Guan, Zhanbing Liu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top